EMEA (Europe, Middle East and Africa) Nanopharmaceuticals Market Report 2017

October 2017 | 128 pages | ID: E3F8B1D4A25PEN
QYResearch

Abstracts

In this report, the EMEA Nanopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Nanopharmaceuticals for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nanopharmaceuticals market competition by top manufacturers/players, with Nanopharmaceuticals sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Pfizer
• Novartis
• Abbott
• GlaxoSmithKline
• Roche
• Sanofi
• Eli Lilly
• Astrazeneca
• Johnson & Johnson
• Celgene
• Novavax
• Stryker
• Gilead Sciences
• OSI Pharmaceuticals
• Kadmon Pharmaceuticals
• Samyang Biopharm
• Mitsubishi Pharma
• Kaken Pharmaceutical
• Selecta Biosciences
• Par Pharmaceutical
• Cerulean Pharma
• Navidea Biopharmaceuticals
• Lummy

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Liposomes
• Polymeric Micelles
• Solid Lipid Nanoparticles
• Microemulsion And Nanoemulsion
• Nanosuspension

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Nanopharmaceuticals for each application, including

• Cancer
• Tumor
• Autoimmune Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Nanopharmaceuticals Market Report 2017

1 NANOPHARMACEUTICALS OVERVIEW

1.1 Product Overview and Scope of Nanopharmaceuticals
1.2 Classification of Nanopharmaceuticals
  1.2.1 EMEA Nanopharmaceuticals Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Nanopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Liposomes
  1.2.4 Polymeric Micelles
  1.2.5 Solid Lipid Nanoparticles
  1.2.6 Microemulsion And Nanoemulsion
  1.2.7 Nanosuspension
1.3 EMEA Nanopharmaceuticals Market by Application/End Users
  1.3.1 EMEA Nanopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Cancer
  1.3.3 Tumor
  1.3.4 Autoimmune Disorders
1.4 EMEA Nanopharmaceuticals Market by Region
  1.4.1 EMEA Nanopharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Nanopharmaceuticals (2012-2022)
  1.5.1 EMEA Nanopharmaceuticals Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Nanopharmaceuticals Revenue and Growth Rate (2012-2022)

2 EMEA NANOPHARMACEUTICALS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Nanopharmaceuticals Market Competition by Players/Manufacturers
  2.1.1 EMEA Nanopharmaceuticals Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Nanopharmaceuticals Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Nanopharmaceuticals Sale Price by Players (2012-2017)
2.2 EMEA Nanopharmaceuticals (Volume and Value) by Type/Product Category
  2.2.1 EMEA Nanopharmaceuticals Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Nanopharmaceuticals Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Nanopharmaceuticals Sale Price by Type (2012-2017)
2.3 EMEA Nanopharmaceuticals (Volume) by Application
2.4 EMEA Nanopharmaceuticals (Volume and Value) by Region
  2.4.1 EMEA Nanopharmaceuticals Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Nanopharmaceuticals Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Nanopharmaceuticals Sales Price by Region (2012-2017)

3 EUROPE NANOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Nanopharmaceuticals Sales and Value (2012-2017)
  3.1.1 Europe Nanopharmaceuticals Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Nanopharmaceuticals Revenue and Growth Rate (2012-2017)
3.2 Europe Nanopharmaceuticals Sales and Market Share by Type
3.3 Europe Nanopharmaceuticals Sales and Market Share by Application
3.4 Europe Nanopharmaceuticals Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Nanopharmaceuticals Sales Volume by Countries (2012-2017)
  3.4.2 Europe Nanopharmaceuticals Revenue by Countries (2012-2017)
  3.4.3 Germany Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.4 France Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.5 UK Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.6 Russia Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.7 Italy Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Nanopharmaceuticals Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NANOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Nanopharmaceuticals Sales and Value (2012-2017)
  4.1.1 Middle East Nanopharmaceuticals Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Nanopharmaceuticals Revenue and Growth Rate (2012-2017)
4.2 Middle East Nanopharmaceuticals Sales and Market Share by Type
4.3 Middle East Nanopharmaceuticals Sales and Market Share by Application
4.4 Middle East Nanopharmaceuticals Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Nanopharmaceuticals Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Nanopharmaceuticals Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  4.4.4 Israel Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  4.4.5 UAE Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  4.4.6 Iran Nanopharmaceuticals Sales and Growth Rate (2012-2017)

5 AFRICA NANOPHARMACEUTICALS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Nanopharmaceuticals Sales and Value (2012-2017)
  5.1.1 Africa Nanopharmaceuticals Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Nanopharmaceuticals Revenue and Growth Rate (2012-2017)
5.2 Africa Nanopharmaceuticals Sales and Market Share by Type
5.3 Africa Nanopharmaceuticals Sales and Market Share by Application
5.4 Africa Nanopharmaceuticals Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Nanopharmaceuticals Sales Volume by Countries (2012-2017)
  5.4.2 Africa Nanopharmaceuticals Revenue by Countries (2012-2017)
  5.4.3 South Africa Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Nanopharmaceuticals Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Nanopharmaceuticals Sales and Growth Rate (2012-2017)

6 EMEA NANOPHARMACEUTICALS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nanopharmaceuticals Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Nanopharmaceuticals Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Nanopharmaceuticals Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Nanopharmaceuticals Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Nanopharmaceuticals Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Nanopharmaceuticals Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Nanopharmaceuticals Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eli Lilly
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Nanopharmaceuticals Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Astrazeneca
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Nanopharmaceuticals Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Nanopharmaceuticals Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Celgene
6.12 Novavax
6.13 Stryker
6.14 Gilead Sciences
6.15 OSI Pharmaceuticals
6.16 Kadmon Pharmaceuticals
6.17 Samyang Biopharm
6.18 Mitsubishi Pharma
6.19 Kaken Pharmaceutical
6.20 Selecta Biosciences
6.21 Par Pharmaceutical
6.22 Cerulean Pharma
6.23 Navidea Biopharmaceuticals
6.24 Lummy

7 NANOPHARMACEUTICALS MANUFACTURING COST ANALYSIS

7.1 Nanopharmaceuticals Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nanopharmaceuticals

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nanopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nanopharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NANOPHARMACEUTICALS MARKET FORECAST (2017-2022)

11.1 EMEA Nanopharmaceuticals Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Nanopharmaceuticals Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Nanopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Nanopharmaceuticals Price and Trend Forecast (2017-2022)
11.2 EMEA Nanopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nanopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nanopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nanopharmaceuticals Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nanopharmaceuticals Sales Forecast by Type (2017-2022)
11.7 EMEA Nanopharmaceuticals Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nanopharmaceuticals
Figure EMEA Nanopharmaceuticals Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Nanopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Liposomes Product Picture
Figure Polymeric Micelles Product Picture
Figure Solid Lipid Nanoparticles Product Picture
Figure Microemulsion And Nanoemulsion Product Picture
Figure Nanosuspension Product Picture
Figure EMEA Nanopharmaceuticals Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Nanopharmaceuticals by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Autoimmune Disorders Examples
Table Key Downstream Customer in Autoimmune Disorders
Figure EMEA Nanopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure Europe Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nanopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nanopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nanopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nanopharmaceuticals Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nanopharmaceuticals Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Nanopharmaceuticals Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Nanopharmaceuticals Sales Share by Players (2012-2017)
Figure 2016 Nanopharmaceuticals Sales Share by Players
Figure 2017 Nanopharmaceuticals Sales Share by Players
Figure EMEA Nanopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nanopharmaceuticals Revenue (Million USD) by Players (2012-2017)
Table EMEA Nanopharmaceuticals Revenue Share by Players (2012-2017)
Table 2016 EMEA Nanopharmaceuticals Revenue Share by Players
Table 2017 EMEA Nanopharmaceuticals Revenue Share by Players
Table EMEA Nanopharmaceuticals Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Nanopharmaceuticals Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Nanopharmaceuticals Sales Share by Type (2012-2017)
Figure Sales Market Share of Nanopharmaceuticals by Type (2012-2017)
Figure EMEA Nanopharmaceuticals Sales Market Share by Type (2012-2017)
Table EMEA Nanopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nanopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nanopharmaceuticals by Type in 2016
Table EMEA Nanopharmaceuticals Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Nanopharmaceuticals Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Nanopharmaceuticals Sales Share by Application (2012-2017)
Figure Sales Market Share of Nanopharmaceuticals by Application (2012-2017)
Figure EMEA Nanopharmaceuticals Sales Market Share by Application in 2016
Table EMEA Nanopharmaceuticals Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Nanopharmaceuticals Sales Share by Region (2012-2017)
Figure Sales Market Share of Nanopharmaceuticals by Region (2012-2017)
Figure EMEA Nanopharmaceuticals Sales Market Share in 2016
Table EMEA Nanopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nanopharmaceuticals Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nanopharmaceuticals by Region (2012-2017)
Figure EMEA Nanopharmaceuticals Revenue Market Share Regions in 2016
Table EMEA Nanopharmaceuticals Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Nanopharmaceuticals Revenue and Growth Rate (2012-2017)
Table Europe Nanopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Europe Nanopharmaceuticals Market Share by Type (2012-2017)
Figure Europe Nanopharmaceuticals Market Share by Type in 2016
Table Europe Nanopharmaceuticals Sales (K Units) by Application (2012-2017)
Table Europe Nanopharmaceuticals Market Share by Application (2012-2017)
Figure Europe Nanopharmaceuticals Market Share by Application in 2016
Table Europe Nanopharmaceuticals Sales (K Units) by Countries (2012-2017)
Table Europe Nanopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Nanopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Nanopharmaceuticals Sales Market Share by Countries in 2016
Table Europe Nanopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Europe Nanopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Nanopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Nanopharmaceuticals Revenue Market Share by Countries in 2016
Figure Germany Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure France Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure UK Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nanopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Middle East Nanopharmaceuticals Market Share by Type (2012-2017)
Figure Middle East Nanopharmaceuticals Market Share by Type (2012-2017)
Table Middle East Nanopharmaceuticals Sales (K Units) by Applications (2012-2017)
Table Middle East Nanopharmaceuticals Market Share by Applications (2012-2017)
Figure Middle East Nanopharmaceuticals Sales Market Share by Application in 2016
Table Middle East Nanopharmaceuticals Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Nanopharmaceuticals Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nanopharmaceuticals Sales Volume Market Share by Countries in 2016
Table Middle East Nanopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nanopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Nanopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Nanopharmaceuticals Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nanopharmaceuticals Sales (K Units) by Type (2012-2017)
Table Africa Nanopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Nanopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Nanopharmaceuticals Sales Market Share by Type in 2016
Table Africa Nanopharmaceuticals Sales (K Units) by Application (2012-2017)
Table Africa Nanopharmaceuticals Sales Market Share by Application (2012-2017)
Figure Africa Nanopharmaceuticals Sales Market Share by Application (2012-2017)
Table Africa Nanopharmaceuticals Sales Volume (K Units) by Countries (2012-2017)
Table Africa Nanopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Nanopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Nanopharmaceuticals Sales Market Share by Countries in 2016
Table Africa Nanopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Africa Nanopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Nanopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Nanopharmaceuticals Revenue Market Share by Countries in 2016
Figure South Africa Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Table Merck Nanopharmaceuticals Basic Information List
Table Merck Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Merck Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Pfizer Nanopharmaceuticals Basic Information List
Table Pfizer Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Pfizer Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Novartis Nanopharmaceuticals Basic Information List
Table Novartis Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Novartis Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Abbott Nanopharmaceuticals Basic Information List
Table Abbott Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Abbott Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Nanopharmaceuticals Basic Information List
Table GlaxoSmithKline Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Roche Nanopharmaceuticals Basic Information List
Table Roche Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Roche Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Sanofi Nanopharmaceuticals Basic Information List
Table Sanofi Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Sanofi Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Nanopharmaceuticals Basic Information List
Table Eli Lilly Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Astrazeneca Nanopharmaceuticals Basic Information List
Table Astrazeneca Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astrazeneca Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Astrazeneca Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Astrazeneca Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Nanopharmaceuticals Basic Information List
Table Johnson & Johnson Nanopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Nanopharmaceuticals Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Nanopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Nanopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Celgene Nanopharmaceuticals Basic Information List
Table Novavax Nanopharmaceuticals Basic Information List
Table Stryker Nanopharmaceuticals Basic Information List
Table Gilead Sciences Nanopharmaceuticals Basic Information List
Table OSI Pharmaceuticals Nanopharmaceuticals Basic Information List
Table Kadmon Pharmaceuticals Nanopharmaceuticals Basic Information List
Table Samyang Biopharm Nanopharmaceuticals Basic Information List
Table Mitsubishi Pharma Nanopharmaceuticals Basic Information List
Table Kaken Pharmaceutical Nanopharmaceuticals Basic Information List
Table Selecta Biosciences Nanopharmaceuticals Basic Information List
Table Par Pharmaceutical Nanopharmaceuticals Basic Information List
Table Cerulean Pharma Nanopharmaceuticals Basic Information List
Table Navidea Biopharmaceuticals Nanopharmaceuticals Basic Information List
Table Lummy Nanopharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nanopharmaceuticals
Figure Manufacturing Process Analysis of Nanopharmaceuticals
Figure Nanopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nanopharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Nanopharmaceuticals
Table Distributors/Traders List
Figure EMEA Nanopharmaceuticals Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Nanopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nanopharmaceuticals Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Nanopharmaceuticals Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Nanopharmaceuticals Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nanopharmaceuticals Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nanopharmaceuticals Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nanopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Nanopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nanopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nanopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nanopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Nanopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nanopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nanopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nanopharmaceuticals Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Nanopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nanopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nanopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nanopharmaceuticals Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Nanopharmaceuticals Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nanopharmaceuticals Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Nanopharmaceuticals Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources